New paper published corroborating ENA utility
A recent paper further corroborates the utility of Enphasys patented Enabling Absorption Device in evaluating performance of yet another type of oral drug formulation
Read moreNews & Announcements
We are constantly evolving
our services and business. See what is going on here
Media
Latest News
Enphasys selected to represent Swedish innovation in the U.S.
Daniel Bergström will represent Enphasys and its ground breaking technology for animal free oral drug formulation lead candidate selection at the upcoming SIREUS Entrepreneurship Forum in Colorado, USA, 14-17 Feb.
Read more
Enphasys CEO elected member of IVA
Prof. Christel Bergström has been elected member of the Royal Swedish Academy of Engineering Sciences (IVA)
Read more
Enphasys granted US patent
The ENA may replace animal experiments in drug formulation development, save cost and reduce time to market
Read more
This project has recieved funding by the European Union's Horizon 2020 research and innovation programme under grant agreement No 836869
